Multiple Sclerosis Immunology A Foundation for Current and Future Treatments /
The availability of powerful genome-wide association study technology, during the last five years, has shown that most of the “new” MS susceptibility loci are immune-response genes. It is clear that there is much novelty in the field of MS immunology, which has served as an impetus to invest in new...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Th17 cells in autoimmune inflammation and demyelination in the central nervous system
- Regulatory T cells in MS
- T-bet: A critical regulator of encephalitogenic T Cells
- Antigen-presenting cells in the Central Nervous System
- The role of B cells in multiple sclerosis
- Diet, gut flora and multiple sclerosis: current research and future perspectives
- GM-CSF in autoimmune inflammation of the central nervous system
- The role of Toll-like receptors in multiple sclerosis and experimental autoimmune encephalomyelitis
- Macrophages and microglia in experimental autoimmune encephalomyelitis and multiple sclerosis
- Genetics of multiple sclerosis
- Gene expression profiling and pathway analysis for identification of molecular targets in MS
- Systems biology for the study of multiple sclerosis
- Checkpoints in the development of pathogenic and regulatory T cells in Experimental Autoimmune Encephalomyelitis—a basis for current future interventions in MS
- Modeling MS in non-human primates
- A novel concept of treatment in MS: targeting both oligodendrocyte death and inflammatory processes by inhibiting poly (ADP-Ribose) polymerase
- Association of MS with other autoimmune diseases
- Current and future treatments of Multiple Sclerosis
- Targeting CD52 for the treatment of Multiple Sclerosis
- Haematopoietic stem cells for the treatment of MS
- Mesenchymal stem cells for the treatment of Multiple Sclerosis.
